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Introduction: Bleeding from mucosal edges is known to decrease surgical visibility and increase the risk
of complications in Endoscopic sinus surgery (ESS). A variety of strategies, including modifying anesthetic
techniques have been proposed to create a bloodless field. A recent survey in anesthesiologist revealed
that a vast majority neither use controlled hypotension nor believe that modifying the anesthetic tech-
niques will improve the outcome of ESS. This study investigates the different anesthetic techniques used
for ESS and their effect on the haemodynamic variables achieved intra-operatively.
Methods: Data were retrospectively collected from an electronic anesthesia database on 233 consecutive
adult patients who underwent endoscopic sinus surgery in a tertiary hospital in Singapore from January
2014 to August 2015 and statistical analysis was performed using SPSS.
Results: Inhaled anesthetics (IA) were used for 93% (49% with morphine or fentanyl, 42% with remifen-
tanil) and total intravenous anesthesia (TIVA) for 7% of the cases respectively. The airway was secured
with endotracheal tube in 94.6% and the rest were having LMA. Average Mean Arterial Pressure (MAP)
lower than 70 mmHg was achieved in 74.4%. Antihypertensive drugs were used only in 5 cases (2.3%).
Distribution of intra operative MAP and Heart rate (HR) were similar among different anesthetic tech-
niques. Lowest MAP and HR achieved were significantly lower in IA with remifentanil use.
Conclusion: Inhaled anesthesia is the preferred maintenance technique used for ESS. The desired MAP
range was achieved in about 75% of the cases without needing anti hypertensives. Use of remifentanil
reduces the MAP and HR further which might potentially improve the quality of surgical field and the
outcome.
 2016 Publishing services by Elsevier B.V. on behalf of Egyptian Society of Anesthesiologists. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Endoscopic sinus surgery (ESS) is a widely used surgical inter-
vention for treatment of various sinus pathologies [1]. Bleeding
from mucosal edges is known to decrease surgical visibility and
increase the risk of complications [2]. Optimized surgical field in
ESS has been proven to improve surgical outcomes, reduce operat-
ing time and lessen blood loss [3]. A variety of strategies have been
proposed to create a bloodless field: (a) patient positioning in
reverse Trendelenburg to decrease venous congestion of the upper
part of the body [4], (b)administration of topical vasoconstrictors
to nasal mucosa to decrease capillary bleeding [5], (c) anestheticmodifications like the use of a laryngeal mask airway to decrease
hemodynamic responses to endotracheal intubation [6], (d)
‘‘high-frequency” jet ventilation to improve venous return [7]
and (e) manipulation of ventilator settings to avoid hypercarbia
which is a potent vasodilator [8]. Controlled hypotension is
another widely used method to reduce the surgical bleeding in
otorhinolaryngology, vascular, orthopedic and orthognathic surg-
eries. Controlled hypotension is defined as a fall in systolic blood
pressure (SBP) to 80–90 mmHg, or mean arterial pressure (MAP)
to 50–65 mmHg in normotensive patients, or a fall of 30% of MAP
in patients with hypertension [9]. The state of hypotension is
achieved by reducing the systemic vascular resistance or cardiac
output, which is determined by stroke volume and heart rate.
A recent questionnaire survey done in Singapore found that
almost 65% do not routinely employ controlled hypotension for
ESS and 47% opined that anesthetic technique made no substantial
divergence in outcomes of endoscopic sinus surgery [10]. This
Table 1
Summary of patient demographic data and health status.
Characteristics Mean (SD)
Age (years) 49.37 (15.14)
Height (m) 1.64 (0.10)
Weight (kg) 66.62 (14.08)
BMI (kg m2) 24.65 (4.59)
Duration of anesthesia (min) 122.88 (51.4)
Duration of surgery (min) 96.48 (50.9)
Average baseline MAP (mmHg)
Patients with known hypertensiona 98.76 (12.26)
Patients without hypertension 91.03 (12.19)
Characteristics Number (%)
ASA score
1 75 (33.48%)
2 136 (60.71%)
3 13 (5.80%)
Gender
Male 126 (56.25%)
Female 98 (43.75%)
History of hypertension
Yes 70 (31.25%)
No 154 (68.75%)
Data is presented as mean (standard deviation) or number (Percentage).
BMI – body mass index, ASA score – American Society of Anaesthesiologists’ clas-
sification of Physical Health, MAP – mean arterial pressure.
a Mean of baseline MAP (mmHg) in patents already diagnosed to have
hypertension.
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ability to achieve MAP within the ranges that minimize surgical
bleeding just by being under general anesthesia (GA). Alterna-
tively, the surgeons may be able to achieve good visual fields under
normotensive range by non anesthetic techniques. This retrospec-
tive study aims to investigate the hemodynamic parameters
achieved during surgery, the various anesthetic techniques used
for ESS and the outcome of those techniques along the intra oper-
ative hemodynamic variables.
2. Methods
This study protocol was developed in accordance to the STROBE
(Strengthening the Reporting of Observational studies in Epidemi-
ology) guidelines for reporting cross sectional studies and was
approved by the Sing health Centralized Institutional Review Board
with the waiver of informed consent (CIRB No 2015/2864).
A total of 233 patients who had general anesthesia for ESS in
major operating theatre from January 2014 to August 2015 were
identified from an electronic surgical data base. All the patients’
electronic pre-anesthetic documents and intra-operative anesthe-
sia charts were reviewed by study members. We searched the fol-
lowing information from the pre-operative anesthetic document;
Height, weight, BMI, age, gender, ASA status and history of hyper-
tension and base line mean arterial pressure (MAP) at pre-
operative evaluation clinic or at wards during anesthetic review.
Electronic anesthesia chart was reviewed in detail to obtain (1)
type of anesthesia used for maintenance (Inhalational or TIVA),
(2) choice of airway technique used (type of endotracheal tube or
Supra glottis airway), (3) drugs used for controlled hypotension
(remifentanil, anti-hypertensive), (4) opioids administered and
dose, (5) highest/lowest and average MAP and Heart rate (HR)
achieved during surgery (excluding hemodynamic changes during
induction and emergence of anesthesia), (6) mode of ventilation,
(7) average ETCO2 range, (8) duration of anesthesia and (9) dura-
tion of surgery.
Average MAP was classified into MAP less than 50, 51–60, 61–
70, 71–80 and above 80 mmHg. Average HR was categorized to
HR under 40, 41–50, 51–60, 61–70 and 71–80 and above 80 beats
per minute. Average ETCO2 was classified to ETCO2 under 30, 30–
35, 36–40, 41–45 and above 45 mmHg. The ETCO2 was docu-
mented as a graph in the electronic anesthesia document. From
the ETCO2 trace, tentative baseline ETCO2 was calculated for each
15-min time block, and the intra-operative average was derived
from the values of 15 min blocks.
3. Statistical methods
Statistical analysis was performed using SPSS for Mac version
20.0 (SPSS Inc., Chicago, IL, USA). Continuous variables were
reported as mean values (SD). Categorical variables were reported
as numbers (percentage). Normality for continuous variables into
groups was determined by the Shapiro-Wilk test. One-way analy-
sis of variance (ANOVA), Dunnett’s test and student’s t-test were
applied for comparison of continuous variables between the exam-
ined groups. Pearson chi-square test was applied for comparison of
categorical variables among studied groups. A p value below 0.05
was considered statistically significant.
4. Results
We reviewed 233 anesthetic documents and nine cases were
excluded. Of those, eight cases were due to wrong surgical coding
and one due to cancellation of surgery after induction of anesthe-
sia. Data were obtained from 224 cases and used for the analysis.Please cite this article in press as: Suhitharan T et al. . Egypt J Anaesth (2016)The average age (SD) of our patient cohort was 49 (15) years
with 56% males and remaining 44% patients were females. The
majority of the patients (60.7%) belonged to the American Society
of Anesthetists (ASA) 2 class, while 33.5% were ASA 1 and 5.8% ASA
3 respectively. Seventy (31.2%) patients were known to have
hypertension with the mean (SD) MAP of 98.7 (12.2) mmHg at
the time of pre-operative visit, while the rest (68.7%) of the nor-
motensive patient had the mean (SD) MAP was 91.03 (12.1). Mean
(SD) duration of anesthesia was 122.88 (51.4) min and the surgery
was 91.03 (50.9) min (Table 1).
4.1. Anesthetic techniques
The airway was secured with endotracheal intubation in 212
(94.6%) patients, while the laryngeal mask airway was used in 12
(5.4%). The most popular choice of the endotracheal tube (ETT)
used was armored tube, documented in 149 (66.5%) cases. RAE
(Ring, Adair and Elwyn) preformed south tube and normal Portex
ETT were used in 62 (27.7%) and one (0.45%) case respectively. Vol-
ume controlled ventilation was chosen in 214 (95.5%) patients,
pressure control ventilation in six (2.7%) patients. Two (0.89%)
patients each were ventilated using synchronized intermittent
mandatory ventilation (SIMV) mode and spontaneous respiration.
Anesthesia was maintained with inhaled anesthetic (IA) alone in
110 (49.1%) patients and a combination of IA and remifentanil
(IA-R) in 94 (42%) patients. A combination of Total intravenous
anesthesia (TIVA) with propofol and remifentanil was used in 16
(7.4%) and IA, propofol and remifentanil were administered to 4
(1.8%) patients. Almost all the patients (99.5%) received at least
one opioid except one patient who didn’t receive any (Table 2).
4.2. Intra-operative hemodynamic variables
The mean (SD) of lowest and highest MAP values were 55.57
(8.88) mmHg and 82.59 (13.7) mmHg respectively. The average
MAP was 70 mmHg or below in 167 (74.55%) and above 70 mmHg
in 57 (25.45%) cases (Fig. 1)., http://dx.doi.org/10.1016/j.egja.2016.10.005
Table 2
Summary of anesthetic techniques.
Characteristics Number (%)
GA techniques
Inhaled anesthetic 110 (49.11%)
Inhaled anesthetic with remifentanil 94 (41.96%)
IV propofol with remifentanil 16 (7.14%)
Inhaled anesthetic + IV Propofol + Remifentanil 4 (1.79%)
Airway technique
ETT 212 (94.64%)
Normal 1 (0.45%)
RAE 62 (27.68%)
Armoured 149 (66.52%)
LMA 12 (5.36%)
Classical 6 (2.68%)
Proseal 1 (0.45%)
Supreme 4 (1.79%)
Reinforced 1 (0.45%)
Mode of ventilation
VCV 214 (95.54%)
PCV 6 (2.68%)
SIMV 2 (0.89%)
Spontaneous 2 (0.89%)
Intra-operative use of anti-hypertensive
No 219 (97.77%)
Yes 5 (2.23%)
Labetalol 4 (1.79%)
Esmolol 1 (0.45%)
Intra-operative opioids
No 1 (0.45%)
Yes 223 (99.55%)
Morphine only 28 (12.50%)
Fentanyl only 13 (5.80%)
Remifentanil only 8 (3.57%)
Fentanyl + morphine 71 (31.70%)
Remifentanil + fentanyl 3 (1.34%)
Remifentanil + morphine 92 (41.07%)
Morphine + fentanyl + remifentanil 8 (3.57%)
Data is presented as number (Percentage).
ETT – Endotracheal tube, LMA – Laryngeal mask airway, VCV – Volume Controlled
Ventilation, PCV – Pressure Controlled Ventilation, SMIV – Synchronized Mandatory
Intermittent Ventilation.
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57.7 (10.18) and 75.1 (12.81) beats per minute respectively. Aver-
age intraoperative HR was below 70 in 175 (78.12%) and 70 or
above in 49 (21.88%) patients (Fig. 2).
The MAP ranges were classified into 5 groups and the distribu-
tion of MAP ranges were comparable among the three anesthetic
techniques (p value 0.26). Similarly, there was no difference in dis-Figure 1. Distribution of intr
Please cite this article in press as: Suhitharan T et al. . Egypt J Anaesth (2016)tribution of heart rate ranges among 3 groups of anesthetic tech-
niques used. When the subgroups of MAPs were analyzed
individually, they remained comparable among the 3 anesthetic
techniques. By contrast means of lowest and highest intra-
operative MAP and means of lowest and highest HR differed statis-
tically between the 3 anesthetic techniques (Table 3). Dunnett’s
test was done to explore the difference in extremes of MAP and
HR between the anesthetic techniques. We found a significant dif-
ference only between IA and IA-R and the other groups were sim-
ilar with regards to highest and lowest MAP and HR.
Distributions of MAP ranges and HR ranges were comparable
between hypertensive and normotensive subjects. There was no
difference in means of highest and lowest MAP and highest and
lowest HR between patients known to hypertension and nor-
motensive (Table 4).5. Discussion
This retrospective cross sectional study found that IA with mor-
phine or fentanyl is the most popular anesthetic practice (49%) for
ESS followed by IA-R (42%) and TIVA (7%). There was no significant
difference in the average intra-operative MAP or HR among these 3
different practices. However, combining remifentanil to IA signifi-
cantly reduced the lowest MAP and HR during the surgery.
IA and TIVA were given to 93% and 7% respectively in this cohort
of patients undergoing ESS. This is almost similar to our previous
finding of only 10.5% of the anesthesiologists in Singapore public
sector preferred to use TIVA for ESS [9]. The airway was secured
with ETT in 94.6% despite of the added benefits of LMA such as
smooth emergence, reduced hemodynamic volatility and a reduc-
tion in the opioid requirement to maintain the MAP in hypotensive
range [6]. This could imply an institutional practice or simply that
the anesthesiologists were more concerned about the dangerous
consequences of airway contamination with gastric contents [11]
over the potential benefits of using LMA.
Moderate hypotension is defined as MAP of 60–70 mmHg,
which has been shown by many studies to provide good surgical
outcomes without compromising the patient safety in ESS
[12,13]. We found that the target MAP for ESS (below 70 mmHg)
was achieved in 164 subjects (74.4%). This MAP target was
achieved in 73% of IA, 82% of the IA-R and 75% of TIVA group
respectively. Antihypertensive were administered only in 5 cases
(2.3%). Ability to achieving required range of MAP with adequate
anesthesia and analgesia without using antihypertensives in our
patient cohort justifies the reason for 65% of anesthetists do not
routinely employ controlled hypotension for ESS in the surveya-operative MAP ranges.
, http://dx.doi.org/10.1016/j.egja.2016.10.005
Figure 2. Distribution of intra-operative HR ranges.
Table 3
Comparison of patient‘s hemodynamic variables between different anesthetic techniques.
Anesthesia techniques IA alone (N = 110) IA with remifentanil (N = 94) IV propofol with remifentanil (N = 16) P values
Hemodynamic variable Subtotal no. (%) Subtotal no. (%) Subtotal no. (%)
Average MAP ranges 0.226 (over all)
<50 0 (0%) 1 (1.06%) 0 (0%) 0.510
51–60 24 (21.82%) 25 (26.60%) 2 (12.50%) 0.416
61–70 49 (44.55%) 52 (55.32%) 10 (62.50%) 0.187
71–80 25 (22.73%) 12 (12.77%) 2 (12.50%) 0.152
>80 12 (10.91%) 4 (4.26%) 2 (12.50%) 0.181
Average Heart rate ranges 0.137 (over all)
40–49 5 (4.55%) 10 (10.64%) 0 (0%)
50–59 27 (24.55%) 33 (35.11%) 4 (25.00%)
60–69 49 (44.55%) 35 (31.82%) 8 (50.00%)
70–79 16 (14.55%) 10 (10.64%) 4 (25.00%)
P80 13 (11.82%) 6 (6.38%) 0 (0%)
Hemodynamic variable Mean (SD) Mean (SD) Mean (SD) P values
Mean of lowest MAP 57.22 (9.35) 53.77 (8.61) 54.13 (4.69) 0.017
Mean of highest MAP 84.91 (14.06) 79.47 (12.92) 83.81 (12.31) 0.016
Mean of lowest HR 59.41 (10.40) 55.50 (10.35) 58.50 (5.76) 0.023
Mean of highest HR 77.39 (13.96) 71.98 (11.42) 78.25 (10.04) 0.007
Significance of bold values is P < 0.05.
Data is presented as mean (standard deviation) or number (Proportion).
MAP – Mean Arterial Pressure (mmHg); Average MAP during intra-operative period excluding induction and emergence.
HR – Heart Rate Average (min1); HR during intra-operative period excluding induction and emergence.
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reverse Trendelenburg position, smooth induction and intubation
techniques with minimal sympathetic stimulation, local anesthetic
infiltration to surgical fields and minimal surgical stimulation [14].
However, achieving MAP in the range of controlled hypotension
with IA may not necessarily improve the quality of visual field
[2] or reduce the blood loss. Higher concentration of IA causes
peripheral vasodilation [15] systemically and locally within the
nasal mucosa in a dose dependant manner. This can possibly result
in tachycardia, and increase capillary bleeding despite that systolic
blood pressure is low [16].
Furthermore, this study showed that combining remifentanil
infusion with IA decreases the MAP below 70 mmHg in 17% of
patients and maintains HR below 60 beats/minute in 11% of
patients. The overall effect of remifentanil on the quality of the sur-
gical field and blood loss is proven to be significant [17,18]. This is
attributed to its hypotensive and bradycardic effects without the
causing peripheral vasodilatation [19]. For this reason, remifen-
tanil could be considered as a first line agent to achieve hypoten-
sive anesthesia for head and neck surgeries. However, if IA is
used to titrate the MAP, inappropriate usage of higher doses of IAPlease cite this article in press as: Suhitharan T et al. . Egypt J Anaesth (2016)could be a source of additional vasodilation in the surgical field,
predisposing to worse visual field scores [3,13]. The average and
extremes of MAP or HR of TIVA group were comparable to IA and
IA-R group in our patient cohort. However, the synergistic effect
of remifentanil with propofol as TIVA [20] is shown to have lower
MAP [2] and HR [3] compared to IA (sevoflurane) in ESS. We
couldn’t demonstrate this due to less number of patients in TIVA
group.
A recent study evaluating the patients undergoing hypotensive
anesthesia for ESS found that reducing MAP improved bleeding
scores, a strong association with reduction of middle cerebral
artery blood flow velocity (Vmca) as measured by transcranial
Doppler ultrasonography [21]. The results from this study sug-
gested that based on Vmca flows, reducing MAP below 60 mmHg
may increase cerebral ischemia risk. Comparisons of intra-
operative MAP range between known hypertensives and nor-
motensives in our cohort showed that average MAP was below
60 mmHg in 18.5% of hypertensives and 26% of normotensives.
This would illustrate that the anesthesiologist were aware of the
possible risk of cerebral ischemia and practice cautiously in the
hypertensive group who are at higher risk. However, if hypotensive, http://dx.doi.org/10.1016/j.egja.2016.10.005
Table 4
Comparison of hemodynamic variables between hypertensive and normotensive
patients.
Known status Hypertensive
(N=70)
Normotensive
(N = 154)
P values
Hemodynamic
variable
Subtotal
no. (%)
Subtotal
no. (%)
MAP ranges 0.385 (over all)
<50 1 (1.43%) 0 (0%) 0.137
51–60 12 (17.14%) 40 (25.97%) 0.147
61–70 38 (54.29%) 76 (49.35%) 0.493
71–80 13 (18.57%) 26 (16.88%) 0.758
>80 6 (8.57%) 12 (7.79%) 0.841
Heart rate ranges 0.250
40–49 6 (8.57%) 9 (5.84%)
50–59 26 (37.14%) 38 (24.68%)
60–69 27 (38.57%) 69 (44.81%)
70–79 7 (10.00%) 23 (14.94%)
P80 4 (5.71%) 15 (9.74%)
Hemodynamic variable Mean (SD) Mean (SD) P values
Mean of lowest MAP 56.59 (8.44) 55.10 (9.06) 0.248
Mean of highest MAP 84.69 (13.50) 81.64 (13.73) 0.124
Mean of lowest HR 55.87 (10.24) 58.57 (10.07) 0.066
Mean of highest HR 73.59 (13.12) 75.80 (12.65) 0.232
Data is presented as mean (standard deviation) or number (Proportion).
MAP – Mean Arterial Pressure (mmHg); Average MAP during intra-operative period
excluding induction and emergence.
HR – Heart Rate (min1); Average HR during intra-operative period excluding
induction and emergence.
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gical outcomes, monitoring cerebral function should be attempted
especially in those at higher risk for cerebral ischemia. Continuous
monitoring of cerebral oxygenation, such as Near Infrared Spec-
troscopy (NIRS), could be a feasible option here.
This study has several limitations. Firstly the data are from a
single institution and the practices may be differ in other centres.
However the proportions of anesthetic techniques used in our
study are similar to the findings of a local survey done in all the
public health institutions [9]. Furthermore our institution has
anesthesiologists trained locally and internationally and who prac-
tice a diverse range of anesthetic techniques for ESS. Secondly, this
is a retrospective cross sectional study and it may not be possible
to identify or address all the anesthetic and surgical confounds
influencing the outcomes such as Minimum alveolar concentration
(MAC) of inhalation anesthetics, remifentanil infusion rate and dif-
ferent surgical techniques used to reduce the blood loss. However,
our study was done to explore the effects of anesthetic techniques
on intra-operative hemodynamic variables. We believe our retro-
spective study with a good sample size (224) is adequate to answer
the study question. Thirdly, there was a significant difference in the
distribution of cases among different anesthetic practices and only
a few patients (14) received TIVA. This makes it difficult to derive
conclusions using data from the TIVA group. Nevertheless, this
depicts the real world practice of anesthesia for ESS. Fourthly, there
is no record of surgeon satisfaction with the amount of bleeding
and the quality of the visual field. However, it would be unthink-
able that the non-practice of controlled hypotension at an institu-
tion level would have gone unnoticed and uncorrected if visual
field quality suffered.6. Conclusion
Inhalation anesthesia is the preferred maintenance technique
used for ESS. MAP in the moderate hypotensive range or below is
achieved in almost 3 out of 4 cases using the inhalation techniquePlease cite this article in press as: Suhitharan T et al. . Egypt J Anaesth (2016)with fentanyl or morphine. Using remifentanil further decreases
the MAP and HR which could ultimately lead to a better surgical
outcome. However, we are unable to comment on the effects this
finding on the quality of the surgical field and blood loss.Conflicts of interest
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